Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03345810
Title Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) (DURATION)
Acronym DURATION
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AIO-Studien-gGmbH
Indications
Therapies
Age Groups: senior
Covered Countries DEU

Additional content available in CKB BOOST